1. Home
  2. ANF vs RCUS Comparison

ANF vs RCUS Comparison

Compare ANF & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Abercrombie & Fitch Company

ANF

Abercrombie & Fitch Company

N/A

Current Price

$138.05

Market Cap

3.9B

ML Signal

N/A

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

N/A

Current Price

$15.64

Market Cap

3.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ANF
RCUS
Founded
1892
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.2B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
ANF
RCUS
Price
$138.05
$15.64
Analyst Decision
Buy
Strong Buy
Analyst Count
15
15
Target Price
★ $170.64
$40.92
AVG Volume (30 Days)
788.5K
★ 1.9M
Earning Date
11-24-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ 5.59
N/A
Revenue
★ $5,266,292,000.00
$247,000,000.00
Revenue This Year
$5.01
N/A
Revenue Next Year
$4.40
N/A
P/E Ratio
$24.62
★ N/A
Revenue Growth
★ 6.42
N/A
52 Week Low
$65.45
$15.65
52 Week High
$172.00
$31.74

Technical Indicators

Market Signals
Indicator
ANF
RCUS
Relative Strength Index (RSI) 38.81 28.46
Support Level $130.81 N/A
Resistance Level $154.90 $24.80
Average True Range (ATR) 7.92 0.97
MACD -2.74 -0.06
Stochastic Oscillator 5.55 1.23

Price Performance

Historical Comparison
ANF
RCUS

About ANF Abercrombie & Fitch Company

Abercrombie & Fitch Co is a digitally led, omnichannel retailer offering apparel, personal care products, and accessories for men, women, and kids through company-owned stores, digital channels, and third-party arrangements. The company operates through three geographic segments: Americas, the maximum revenue generator; Europe, the Middle East and Africa (EMEA); and Asia-Pacific (APAC). Its brand families include Abercrombie brands and Hollister brands. The Americas segment covers North and South America, EMEA includes Europe, the Middle East and Africa, and APAC includes the Asia-Pacific region, including Asia and Oceania.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: